Mira Pharmaceuticals, Inc.
MIRA
Revenue
0.00
0.000.00%
-Assets
3.02M
▼-793.21k▼-20.83%
3 Months ChangeLiabilities
796.61k
▲144.61k▲22.18%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0001493152-24-042511
2024-10-21
Form 8-K
ID: 0001493152-24-041702
2024-09-12
Form 8-K
ID: 0001493152-24-036057
2024-09-10
Form 8-K
ID: 0001493152-24-035625
2024-08-23
Form 8-K
ID: 0001493152-24-033718
2024-08-13
Form 10-Q
ID: 0001493152-24-031612
2024-08-09
Form 8-K
ID: 0001493152-24-030980
2024-08-08
Form 8-K
ID: 0001493152-24-030684
2024-07-24
Form 8-K
ID: 0001493152-24-028917
2024-07-19
Form 8-K
ID: 0001493152-24-028548